Why Did the FDA Reject Rigel's EUA Application for Its COVID-19 Therapy?

Why Did the FDA Reject Rigel's EUA Application for Its COVID-19 Therapy?

Source: 
Motley Fool
snippet: 
  • The FDA recently refused to grant an EUA for Rigel's Tavalisse in treating COVID-19.
  • Rigel's EUA submission was based on phase 2 results; the FDA wants more data from a phase 3 study.